1. WAVE predicts transcriptional responses from chemistry and cell state1
In the accessible publisher abstract, WAVE uses a variational autoencoder to predict drug-induced gene expression from chemical structures and cells’ baseline transcription. The authors describe applications to cell lines, single cells and lung-cancer candidate screening. This offers a way to prioritise unmeasured perturbations; our access was limited to the accepted article’s abstract, so detailed validation remains unassessed.1
2. Learning which lipid nanoparticles accumulate beyond the liver2
An unreviewed preprint combines lipid chemistry and formulation composition to classify liver versus extrahepatic accumulation across 476 literature-derived nanoparticle formulations. Interpretable models highlight ionizable-lipid features and component proportions, suggesting variables for follow-up delivery experiments. Evaluation used a random train–test split of existing observations; it does not establish that newly designed formulations will deliver RNA effectively in patients.2
3. A multiscale immune model proposes hypotheses for testing3
An unreviewed preprint links cellular, tissue and individual immune states in an intervention-conditioned model, using existing datasets to explore possible therapeutic responses. It nominates IL-36γ alongside SIRPα inhibition as a combination hypothesis, not demonstrated synergy. The framework makes multiscale hypothesis generation worth examining, while its promised partitioning manifest and software release remain unavailable for checking the reported evaluation.3
References
Tianhang Lv; Bojin Chen; Xiaoyue Dai; Meng Gao; Bingjie Zhu; Minjie Shen; Qin Zhu; Jie Liao; Xiaohui Fan. Learning chemical-induced gene expression perturbations with WAVE. Nature Communications; 2026; Peer-reviewed accepted early-release article; final Version of Record pending. DOI: 10.1038/s41467-026-77645-3. Accessed 2026-09-19T16:13:59.678Z.
Source evidence and access
Publisher Abstract and About this article; accessed publisher search exact DOI September19
Evidence paraphrase: beta-VAE integrates chemical structure and basal transcription to predict chemical perturbations in cell lines and single cells; lung-adenocarcinoma candidate-screening application. No numerical accuracy or patient benefit claimed here.
Restricted to publisher abstract/metadata recovered through indexed publisher page; direct opens failed. Full methods and supplements not reviewed.
Asal Mehradfar; Mohammad Shahab Sepehri; Owen Antholine; Varun Shankar; Glen S. Kwon; Salman Avestimehr; Morteza Rasoulianboroujeni. Decoding Extrahepatic Targeting of Lipid Nanoparticles with Interpretable Machine Learning. arXiv; 2026; Unreviewed preprint v1. DOI: 10.48550/arXiv.2609.17721. Accessed 2026-09-19T16:13:59.678Z.
Source evidence and access
PDF sections2.1 and3.2, pages3/6; abstract page1
Evidence paraphrase:476 intravenously administered formulations from81 studies; highest organ IVIS signal assigns liver/non-liver label. Chemistry/formulation descriptors train interpretable models using80/20 stratified random split. No new clinical validation.
Primary abstract/history and PDF abstract, dataset and model-evaluation sections inspected; no computational rerun.
Taoyong Cui; Xi Wang; Zonghang Li; Jinchao Ding; Lingsen You; Yuzhi Xu; Wanghan Xu; Fang Wu; Kejun Ying; Wanli Ouyang; Pheng Ann Heng; Ling Yang; Zhenfei Yin; Yingcheng Wu. An immune world model for multiscale forecasting and therapeutic hypothesis generation. arXiv; 2026; Unreviewed preprint v1; unresolved-candidate recovery. DOI: 10.48550/arXiv.2609.14709. Accessed 2026-09-19T16:13:59.678Z.
Source evidence and access
HTML structured model/results, discussion, Data and code availability; first posting13Sep18:06UTC
Evidence paraphrase: action-conditioned model connects cell/tissue/individual states from existing human datasets. IL36gamma plus SIRPalpha proposal remains prospectively testable, not validated synergy. Versioned partitioning manifest and software are promised future releases.
Primary full HTML inspected including model, selected results, therapeutic hypotheses and data/code availability. No external artefact validation or rerun.
Publication record
Published 2026-09-19.
Sources, selection and claims were checked in an independent AI editorial review, followed by the AI editor's approval. This is not academic peer review.
- 2026-09-19 · Version e3a8a93e · Viewing this version